A review of 6 placebo-controlled medical trials with one,134 overall contributors concluded that cannabinoids (nabiximols, dronabinol, and THC/CBD) were associated with a better average advancement about the Ashworth scale for spasticity in several sclerosis individuals compared with placebo, although this did not achieve statistical significance. During the seventies, the taxonomic https://elagabalusa739smf8.vblogetin.com/profile